验证数据展示
经过测试的应用
Positive FC detected in | human PBMCs |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 5 ul per 10^6 cells in a 100 µl suspension or 5 ul per 100 µl of whole blood. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
CL594-65560 targets HLA-DR in FC applications and shows reactivity with human samples.
经测试应用 | FC Application Description |
经测试反应性 | human |
免疫原 | Human lymphoblastoid B-cell line RPMI 8866 种属同源性预测 |
宿主/亚型 | Mouse / IgG2a |
抗体类别 | Recombinant |
产品类型 | Antibody |
全称 | major histocompatibility complex, class II, DR alpha |
别名 | HLA-DRA, L243, HLA-DRA1, HLA DRB, HLA DRA1 |
计算分子量 | 254 aa, 29 kDa |
GenBank蛋白编号 | BC032350 |
基因名称 | HLA-DRA |
Gene ID (NCBI) | 3122 |
ENSEMBL Gene ID | ENSG00000204287 |
偶联类型 | CoraLite®594 Fluorescent Dye |
最大激发/发射波长 | 588 nm / 604 nm |
形式 | Liquid |
纯化方式 | Protein A purification |
UNIPROT ID | P01903 |
储存缓冲液 | PBS with 0.09% sodium azide. |
储存条件 | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. |
背景介绍
HLA-DR is a member of MHC class II moleculesencoded by the human leukocyte antigen complex on the region 6p21.31 of chromosome 6. HLA-DR is composed of two non-covalently associated transmembrane glycoproteins (the α and β chains), and is primarily expressed on B lymphocytes, monocytes, dendritic cells and thymic epithelial cells (PMID: 33125816). HLA-DR participate in the antigen presentation to CD4+ or CD8+ T cells and is postulated as a general biomarker of sepsis-induced immunosuppression (PMID: 28199206, 32421903).
实验方案
Product Specific Protocols | |
---|---|
FC protocol for CL594 HLA-DR antibody CL594-65560 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |